DIDREX Tablets are indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction. The limited usefulness of agents of this class (See CLINICAL PHARMACOLOGY) should be weighed against possible risks inherent in their use such as those described below.

Dosage should be individualized according to the response of the patient. The suggested dosage ranges from 25 to 50 mg one to three times daily. Treatment should begin with 25 to 50 mg once daily with subsequent increase in individual dose or frequency according to response. A single daily dose is preferably given in mid-morning or mid-afternoon, according to the patient's eating habits. In an occasional patient it may be desirable to avoid late afternoon administration. Use of benzphetamine hydrochloride is not recommended in individuals under 12 years of age.

DIDREX Tablets are supplied as follows:

50 mg (peach, round, imprinted with DIDREX 50, scored)

Bottles of 100................................NDC 0009-0024-01
Bottles of 500................................NDC 0009-0024-02

Store at controlled room temperature 20° to 25° C (68° to 77° F). [see USP]

Manufactured by: MOVA Pharmaceuticals Manati, PR 00674. Revised December 2005. FDA Rev date: 7/8/2000

Bookmark this page: